Novartis scraps sale of £805m assets including Covid-19 hopeful to Aurobindo
Novartis AG on Thursday  (2) scrapped the $1 billion (£0.81bn) sale of US generic pill and skin drug assets to India's Aurobindo Pharma Ltd as...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.